Beauty claims compress complicated evidence into a few words. This database reverses that compression. It maps common label and campaign phrases to the documents a careful buyer, journalist or editor should request, then separates what those documents can support from what they cannot.
This is not a blacklist of permitted and prohibited words. The meaning and legality of a claim depend on exact wording, presentation, jurisdiction and evidence. India, the European Union and the United States use different legal structures, but they share a useful principle: claims should not mislead. India’s Cosmetics Rules state that a cosmetic must not purport or claim a false or misleading idea. The EU’s common criteria add truthfulness, evidential support, honesty, fairness and informed decision-making. In the US, the FDA distinguishes cosmetic claims from claims that cause a product to be regulated as a drug, while the FTC evaluates advertising substantiation.
Reviewed: 11 August 2026. Data provenance: official Indian, EU and US regulatory texts and guidance. This resource does not score individual brands, reproduce confidential dossiers or claim that a regulator approved any listed phrase.
The GlowBareSkin CLAIM Check
Before repeating a claim in an article, product page or social post, ask five questions:
- Claim wording: What exactly is promised? Is there a number, comparator, time period or implied medical outcome?
- Legal category: Is the message a cosmetic appearance/function claim, or does it imply diagnosis, treatment or alteration of body structure? Which country’s rules apply?
- Adequacy: Is the evidence suitable for the claim—consumer perception, instrument measurement, clinical assessment, analytical test or recognised certification?
- Interpretation: What endpoint was actually measured, and what broader conclusion would overstate it?
- Match: Was the finished formula, dose, duration, population and use condition the same as the advertised product?
Cosmetic claims evidence database
| Claim phrase | Useful substantiation | Does not automatically establish | Evidence note |
|---|---|---|---|
|
Measured SPF 30 / broad spectrum / water resistant |
Finished-product testing under the applicable sunscreen standard; correct label directions. | Protection when underapplied, waterproof performance, or identical UVA systems across markets. | Highly method-dependent and jurisdiction-specific. |
|
Performance “24-hour hydration” |
A defined hydration endpoint, time points, instrument or clinical method, sample, comparator and statistics on the finished formula. | Treatment of eczema, barrier repair in every user, or hydration beyond the tested conditions. | Check whether the endpoint was instrument-measured or self-reported. |
|
Testing process “Clinically tested” |
Protocol, participants, controls, endpoints, duration, results and adverse-event reporting. | That results were positive, clinically meaningful, peer reviewed or independently replicated. | “Tested” describes an activity; ask what the test found. |
|
Testing process “Dermatologist tested” |
The dermatologist’s role, test design, sample, endpoint and results. | Dermatologist approval, recommendation, formulation or suitability for every skin type. | Keep separate from “dermatologist approved.” |
|
Comparative “X% brighter” or “reduces the appearance of spots” |
Validated measurement or blinded grading, baseline and comparator, time period and pre-specified analysis. | Disease treatment, permanent pigment removal, or performance outside the tested population. | The measured object—colour value, image analysis or perception—matters. |
|
Perception “9 in 10 agree skin feels smoother” |
Question wording, sample size, eligibility, product-use duration and complete response distribution. | Objective change, clinical superiority or population-wide results. | Consumer perception can support “feel” claims when reported transparently. |
|
Ingredient-led “With niacinamide for barrier support” |
Ingredient identity, concentration/context, formulation compatibility and evidence relevant to the claimed endpoint. | That an ingredient study proves the finished product performs identically. | Ingredient presence is not finished-product efficacy. |
|
Undefined/variable “Hypoallergenic” |
A clearly disclosed brand definition plus appropriate irritation/sensitisation assessment. | Zero allergy risk or universal suitability. FDA states there is no US federal standard governing the term. | Consumers should inspect ingredients and patch-test when appropriate. |
|
Undefined/variable “Natural” or “clean” |
A public definition, scope, thresholds, exclusions and verification method. | Safer, more effective, non-toxic or allergy-free. FDA does not define “natural” for cosmetic labelling. | Treat as a brand standard unless a named certification applies. |
|
Certification “Organic” |
Named certification, certifier, applicable standard and the exact certified scope. | That FDA defines or certifies cosmetics as organic; in the US, USDA rules can apply to eligible agricultural ingredients and labels. | Distinguish ingredient-level from product-level certification. |
|
Ethical/process “Cruelty free” / “not tested on animals” |
A defined supply-chain policy, cut-off date, supplier controls and named certification if used. | A single universal legal definition in every market, or that every ingredient has never historically been tested. | FDA notes US use of these phrases is unrestricted by specific federal legal definitions. |
|
Category language “Cosmeceutical” |
Evaluate the actual product claims and regulatory category. | A legally recognised FDA product class or premarket approval. | FDA does not recognise “cosmeceutical” as a legal category. |
How evidence should match the claim
Finished-product evidence beats ingredient extrapolation
A study of 5% niacinamide in one vehicle cannot automatically prove that every product listing niacinamide produces the same outcome. Concentration, pH, delivery, co-ingredients, packaging, dose and study population may differ. Ingredient research can support plausibility and explain function; a finished-product performance claim should normally be substantiated by evidence on the finished formula or by a defensible bridge that truly matches it.
Statistical significance is not the entire story
A statistically detectable change can be small. Ask for effect size, uncertainty, comparator and clinical or consumer relevance. A before-and-after image is evidence only when capture conditions are controlled and the selection process is explained. Lighting, exposure, angle, expression and post-processing can change appearance.
Testimonials do not replace substantiation
A testimonial documents one person’s reported experience. It cannot carry a claim that the advertiser could not make directly. If a typical-results qualification is necessary, it should be clear and close to the claim. “Results may vary” does not turn an unsupported promise into adequate evidence.
Jurisdiction map for writers
| Market | Useful starting rule | Editorial question |
|---|---|---|
| India | Cosmetics Rules, 2020: a cosmetic must not purport or claim an idea that is false or misleading. | Does the complete presentation overstate what the evidence shows? |
| European Union | Regulation (EU) No 655/2013 sets common claim criteria including truthfulness and evidential support. | Is the wording honest, fair and supported by adequate, verifiable evidence? |
| United States | FDA classification turns on intended use; FTC advertising guidance addresses substantiation and deceptive claims. | Does wording imply treatment or structure/function change, and is the ad adequately substantiated? |
Claim-audit checklist for beauty writers
- Copy the exact claim, not a paraphrase that makes it stronger.
- Identify the entity making it and the market where it appears.
- Request the study title, protocol, date, formula code and full results—not only a marketing summary.
- Record whether the study tested an ingredient, prototype or final marketed product.
- Check sample size, inclusion criteria, comparator, duration and dropouts.
- Separate measured results from participant opinions.
- Ask whether the analysis and endpoint were chosen before results were known.
- Check whether a named external certification is current and applicable to the whole product.
- Write the limitation in the same paragraph as the result.
For ingredient-name verification, pair this database with the INCI Alias Database. For study design and bias, use How to Read Skincare Studies. Our explanation of “dermatologist approved” provides a deeper audit of that specific phrase.
Citation desk
| Source | Use it for | Limit |
|---|---|---|
| CDSCO Cosmetics overview and Rule 36 context | India’s prohibition on false or misleading cosmetic claims. | Not a ruling on a specific advertisement. |
| EU Regulation 655/2013 | Six common criteria for cosmetic claims. | Apply with current EU law and claim-specific guidance. |
| FTC Health Products Compliance Guidance | Evidence fit, study quality and advertising substantiation principles. | Health-product guidance; exact application is fact-specific. |
| FDA Cosmetic Labeling Claims | Truthfulness and the cosmetic-versus-drug boundary. | FDA does not pre-approve ordinary cosmetic labels. |
| FDA Allergens in Cosmetics | No US federal standard for “hypoallergenic,” “fragrance-free,” or “for sensitive skin.” | Does not mean every use of the phrase is automatically deceptive. |
| USDA organic labelling | Named US organic certification categories and requirements. | Organic status does not prove cosmetic efficacy or universal safety. |
Methodology and limitations
Claims were grouped by the type of proof they usually require: regulated test, objective performance, clinical or consumer assessment, ingredient rationale, process statement, undefined marketing term or third-party certification. Categories overlap. The database reports regulator language and evidence questions; it does not provide legal advice, approve claims or declare products compliant. Rules and guidance change, and regulators evaluate complete context—including imagery, omissions and implied meaning—not isolated words.
Suggested citation: Bathula Meghana. “Cosmetic Claims Evidence Database: What Beauty Claims Prove.” GlowBareSkin, reviewed 11 August 2026, https://www.glowbareskin.com/blogs/glowbareskin/cosmetic-claims-evidence-database.
Frequently asked questions
Does “clinically tested” mean a product works?
No. It means some clinical testing occurred. Ask what was tested, how, against what, in whom and with what result.
Is “dermatologist tested” the same as dermatologist approved?
No. Testing participation does not establish endorsement. Both phrases need a disclosed definition and supporting documentation.
Does natural mean safer?
Not by itself. Source does not determine hazard, dose, exposure or allergy risk. Ask for the brand’s definition and evidence relevant to the actual safety or performance claim.
Can an ingredient study support a product claim?
It can support biological plausibility, but the match must be examined. A different concentration or formulation may not substantiate a quantified finished-product result.
Are cosmetics FDA approved?
In the United States, ordinary cosmetics and their ingredients generally are not pre-approved by FDA, except color additives for intended use. “FDA approved cosmetic” therefore deserves careful verification.
Educational disclaimer: This database is general educational information, not legal, regulatory or medical advice. Requirements vary by jurisdiction and facts; obtain qualified advice for a specific claim or product.
